HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bacterial Infections D001424 21 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases D001847 4 associated lipids
Brain Diseases D001927 27 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Fritzsche FR et al. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. 2008 BMC Cancer pmid:18582378
Skandalis SS et al. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. 2011 BMC Cancer pmid:21791066
El Khoury D et al. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. 2010 BMC Cancer pmid:20573279
Rubie C et al. ELR+ CXC chemokine expression in benign and malignant colorectal conditions. 2008 BMC Cancer pmid:18578857
Ohri CM et al. Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer. 2010 BMC Cancer pmid:20573209
Jiang L et al. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. 2010 BMC Cancer pmid:20569443
Chaube A et al. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582. 2006 BMC Cancer pmid:16686942
Mariani L et al. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. 2010 BMC Cancer pmid:20525370
Di Nicolantonio F et al. Cancer cell adaptation to chemotherapy. 2005 BMC Cancer pmid:16026610
Yan T et al. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. 2011 BMC Cancer pmid:22185371
Kratz JE et al. Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation. 2002 BMC Cancer pmid:12460454
Meyniel JP et al. A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. 2010 BMC Cancer pmid:20492709
Zhang D et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. 2010 BMC Cancer pmid:21108842
Decock J et al. Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis. 2008 BMC Cancer pmid:18366705
Nykopp TK et al. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. 2009 BMC Cancer pmid:19435493
Walker LG et al. Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer. 2011 BMC Cancer pmid:21592370
Ohri CM et al. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. 2010 BMC Cancer pmid:20429924
Chodon D et al. Estrogen regulation of TRPM8 expression in breast cancer cells. 2010 BMC Cancer pmid:20482834
Tong QS et al. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells. 2004 BMC Cancer pmid:15248898
Morrone FB et al. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. 2006 BMC Cancer pmid:16995949
Tuomela J et al. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts. 2010 BMC Cancer pmid:21034500
Valencia T et al. Role and expression of FRS2 and FRS3 in prostate cancer. 2011 BMC Cancer pmid:22078327
Hadad SM et al. Histological evaluation of AMPK signalling in primary breast cancer. 2009 BMC Cancer pmid:19723334
Machado CM et al. Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro. 2008 BMC Cancer pmid:18840301
ten Haaf A et al. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. 2009 BMC Cancer pmid:19706168
Roodink I et al. Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. 2009 BMC Cancer pmid:19703316
Deschoolmeester V et al. Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. 2010 BMC Cancer pmid:20346145
Kempkensteffen C et al. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. 2009 BMC Cancer pmid:19664236
Liu J et al. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas. 2009 BMC Cancer pmid:19653894
Aloysius MM et al. Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer? 2010 BMC Cancer pmid:20202214
Westgaard A et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. 2008 BMC Cancer pmid:18194510
Lööf J et al. Impact of PINCH expression on survival in colorectal cancer patients. 2011 BMC Cancer pmid:21426571
Tomlinson VA et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. 2005 BMC Cancer pmid:16156888
Cheng Y et al. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. 2007 BMC Cancer pmid:17927838
Gockel I et al. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. 2006 BMC Cancer pmid:17176471
Jörissen H et al. Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer. 2009 BMC Cancer pmid:19552806
Arellano-Llamas A et al. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. 2006 BMC Cancer pmid:17067390
Genelhu MC et al. A comparative study between mixed-type tumours from human salivary and canine mammary glands. 2007 BMC Cancer pmid:18045453
Sheahan S et al. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest. 2007 BMC Cancer pmid:18021445
Fu J et al. In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cells. 2011 BMC Cancer pmid:21649908
Zhao C et al. Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. 2010 BMC Cancer pmid:20699000
Seigne C et al. Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. 2010 BMC Cancer pmid:20663219
Boström P et al. MMP-1 expression has an independent prognostic value in breast cancer. 2011 BMC Cancer pmid:21835023
Fernández-Guinea O et al. Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer. 2010 BMC Cancer pmid:20064215
Keightley MC et al. PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer. 2010 BMC Cancer pmid:20840749
Xiaorong L et al. Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. 2008 BMC Cancer pmid:18651974
Zavagno G et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. 2005 BMC Cancer pmid:15762990
Wang J et al. A reproducible brain tumour model established from human glioblastoma biopsies. 2009 BMC Cancer pmid:20040089
Wang J et al. Case report: PET/CT, a cautionary tale. 2007 BMC Cancer pmid:17683560
Wu QW et al. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. 2012 BMC Cancer pmid:22284579